Chronic excess of brain natriuretic peptide in transgenic mice ameliorates diabetic nephropathy by inhibiting high glucose-induced TGF-β expression.

被引:0
|
作者
Makino, H [1 ]
Mukoyama, M [1 ]
Sugawara, A [1 ]
Mori, K [1 ]
Yahata, K [1 ]
Suganami, T [1 ]
Nagae, T [1 ]
Ogawa, Y [1 ]
Tanaka, I [1 ]
Nakao, K [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:317A / 317A
页数:1
相关论文
共 50 条
  • [1] Chronic excess of brain natriuretic peptide in transgenic mice ameliorates renal fibrosis in obstructive nephropathy
    Kasahara, M
    Mukoyama, M
    Sugawara, A
    Mori, K
    Ogawa, Y
    Tanaka, I
    Nakao, K
    JOURNAL OF HYPERTENSION, 2000, 18 : S65 - S65
  • [2] Liver X Receptor Agonist Ameliorates Diabetic Nephropathy by Inhibiting High Glucose-Induced Osteopontin Expression
    Ogawa, Daisuke
    Tachibana, Hiromi
    Wada, Jun
    Terami, Naoto
    Sato-Horiguchi, Chikage
    Shikata, Kenichi
    Makino, Hirofumi
    CIRCULATION, 2012, 126 (21)
  • [3] Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice
    H. Makino
    M. Mukoyama
    K. Mori
    T. Suganami
    M. Kasahara
    K. Yahata
    T. Nagae
    H. Yokoi
    K. Sawai
    Y. Ogawa
    S. Suga
    Y. Yoshimasa
    A. Sugawara
    I. Tanaka
    K. Nakao
    Diabetologia, 2006, 49 : 2514 - 2524
  • [4] Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice
    Makino, H.
    Mukoyama, M.
    Mori, K.
    Suganami, T.
    Kasahara, M.
    Yahata, K.
    Nagae, T.
    Yokoi, H.
    Sawai, K.
    Ogawa, Y.
    Suga, S.
    Yoshimasa, Y.
    Sugawara, A.
    Tanaka, I.
    Nakao, K.
    DIABETOLOGIA, 2006, 49 (10) : 2514 - 2524
  • [5] Liver X receptor agonist ameliorates diabetic nephropathy by inhibiting high glucose-induced osteopontin expression in proximal tubular epithelial cells
    Ogawa, D.
    DIABETOLOGIA, 2012, 55 : S19 - S19
  • [6] Cilostazol ameliorates diabetic nephropathy by inhibiting high-glucose-induced apoptosis
    Chian, Chien-Wen
    Lee, Yung-Shu
    Lee, Yi-Ju
    Chen, Ya-Hui
    Wang, Chi-Ping
    Lee, Wen-Chin
    Lee, Huei-Jane
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2020, 24 (05): : 403 - 412
  • [7] Zuogui Wan ameliorates high glucose-induced podocyte apoptosis and improves diabetic nephropathy in db/db mice
    Zhu, Bingbing
    Fang, Ji
    Ju, Zhengcai
    Chen, Ying
    Wang, Li
    Wang, Hao
    Xing, Lina
    Cao, Aili
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [8] Protocatechuic acid ameliorates high glucose-induced extracellular matrix accumulation in diabetic nephropathy
    Ma, Yali
    Chen, Fang
    Yang, Suxia
    Chen, Baoping
    Shi, Jun
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 98 : 18 - 22
  • [9] Glucose-induced TGF-β1 in skin fibroblasts from type 1 diabetic patients with diabetic nephropathy.
    Thomas, S
    Burt, D
    Vanuystel, J
    Gruden, G
    Gnudi, L
    Viberti, GC
    DIABETOLOGIA, 1998, 41 : A38 - A38
  • [10] C-peptide ameliorates high glucose-induced podocyte dysfunction through the regulation of the Notch and TGF-β signaling pathways
    Luo, Jiao
    Jiang, Jiahong
    Huang, Hongjian
    Jiang, Feifei
    Xu, Zeru
    Zhou, Zijun
    Zhu, Hong
    PEPTIDES, 2021, 142